Literature DB >> 7860461

Cognitive-behavioral psychotherapy for children and adolescents with OCD: a review and recommendations for treatment.

J S March1.   

Abstract

OBJECTIVE: To critically review the published literature on cognitive-behavioral psychotherapy for obsessive-compulsive disorder (OCD) in children and adolescents.
METHOD: The psychiatric and psychological literature was systematically searched for "studies" applying cognitive-behavioral principles to children and adolescents with OCD.
RESULTS: Thirty-two investigations, most of them single case reports, were identified. Despite manifold differences in terminology and theoretical framework, all but one showed some benefit for cognitive-behavioral interventions. Graded exposure and response prevention form the core of treatment; anxiety management training and OCD-specific family interventions may play an adjunctive role. Poor compliance, inadequately documented and inconsistently applied treatment, and lack of exportability were recurrent problems.
CONCLUSIONS: Abundant clinical and emerging empirical evidence suggest that cognitive-behavioral psychotherapy, alone or in combination with pharmacotherapy, is an effective treatment for OCD in children and adolescents. Future research in this area will need to focus on comparisons of cognitive-behavioral psychotherapy to other treatments, on component analyses, and on the application of exportable protocol-driven treatments to divergent patient populations.

Entities:  

Mesh:

Year:  1995        PMID: 7860461     DOI: 10.1097/00004583-199501000-00008

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  18 in total

1.  Obsessive-compulsive disorder: Evidence-based treatments and future directions for research.

Authors:  Caleb W Lack
Journal:  World J Psychiatry       Date:  2012-12-22

Review 2.  A compensatory role for declarative memory in neurodevelopmental disorders.

Authors:  Michael T Ullman; Mariel Y Pullman
Journal:  Neurosci Biobehav Rev       Date:  2015-01-15       Impact factor: 8.989

Review 3.  Predicting the outcome of treatment.

Authors:  J S March; J F Curry
Journal:  J Abnorm Child Psychol       Date:  1998-02

4.  Treatment Efficacy of Combined Sertraline and Guanfacine in Comorbid Obsessive-Compulsive Disorder and Attention Deficit/Hyperactivity Disorder: Two Case Studies.

Authors:  Shibany P Taormina; Matthew P Galloway; David R Rosenberg
Journal:  J Dev Behav Pediatr       Date:  2016 Jul-Aug       Impact factor: 2.225

5.  Group cognitive-behavior therapy with family involvement for middle-school-age children with obsessive-compulsive disorder: a pilot study.

Authors:  Jacqueline L Martin; Margo Thienemann
Journal:  Child Psychiatry Hum Dev       Date:  2005

6.  Predictors of parental accommodation in pediatric obsessive-compulsive disorder: findings from the Pediatric Obsessive-Compulsive Disorder Treatment Study (POTS) trial.

Authors:  Christopher A Flessner; Jennifer B Freeman; Jeffrey Sapyta; Abbe Garcia; Martin E Franklin; John S March; Edna Foa
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-06-12       Impact factor: 8.829

Review 7.  Cognitive behavioral treatment for young children with obsessive-compulsive disorder.

Authors:  Jennifer B Freeman; Molly L Choate-Summers; Phoebe S Moore; Abbe M Garcia; Jeffrey J Sapyta; Henrietta L Leonard; Martin E Franklin
Journal:  Biol Psychiatry       Date:  2007-02-01       Impact factor: 13.382

8.  Examining the Psychometric Properties of the Family Accommodation Scale-Parent-Report (FAS-PR).

Authors:  Christopher A Flessner; Jeffrey Sapyta; Abbe Garcia; Jennifer B Freeman; Martin E Franklin; Edna Foa; John March
Journal:  J Psychopathol Behav Assess       Date:  2009-03

9.  Correlates of comorbid anxiety and externalizing disorders in childhood obsessive compulsive disorder.

Authors:  Audra K Langley; Adam B Lewin; R Lindsey Bergman; Joyce C Lee; John Piacentini
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-03-28       Impact factor: 4.785

Review 10.  A risk-benefit assessment of pharmacotherapy for anxiety disorders in children and adolescents.

Authors:  S M Hawkridge; D J Stein
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.